264 related articles for article (PubMed ID: 17376091)
1. Therapeutic use of erythropoietin in dermatooncology.
Satzger I; Schenck F; Thol F; Ganser A; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2007 Apr; 5(4):280-5. PubMed ID: 17376091
[TBL] [Abstract][Full Text] [Related]
2. [Working group of Dermatologic Oncology ADO. Second-line therapy in stage IV melanoma].
J Dtsch Dermatol Ges; 2007 Oct; 5(10):959. PubMed ID: 17910683
[No Abstract] [Full Text] [Related]
3. [Working Group of the Dermatologic Oncology Society].
Loquai C
J Dtsch Dermatol Ges; 2009 Sep; 7(9):821. PubMed ID: 19712235
[No Abstract] [Full Text] [Related]
4. Current recommendations for prevention and therapy of extravasation reactions in dermato-oncology.
Kähler KC; Mustroph D; Hauschild A
J Dtsch Dermatol Ges; 2009 Jan; 7(1):21-8. PubMed ID: 18479476
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
Vaupel P; Dunst J; Engert A; Fandrey J; Feyer P; Freund M; Jelkmann W
Onkologie; 2005 Apr; 28(4):216-21. PubMed ID: 15840971
[TBL] [Abstract][Full Text] [Related]
6. New research advances for treating metastatic melanoma.
Minutilli E
Int J Dermatol; 2010 Jun; 49(6):712-4. PubMed ID: 20618481
[No Abstract] [Full Text] [Related]
7. Systemic treatment of melanoma: quo vadis oncologist?
Retsas S
J BUON; 2007; 12(1):29-32. PubMed ID: 17436398
[No Abstract] [Full Text] [Related]
8. Anemia: cancer patients who are very likely to benefit often go untreated.
J Support Oncol; 2003; 1(1):68. PubMed ID: 15352647
[No Abstract] [Full Text] [Related]
9. [Outpatient dermatological chemotherapy].
Reinhold U
Hautarzt; 2007 Jan; 58(1):77-92; quiz 93. PubMed ID: 17096136
[TBL] [Abstract][Full Text] [Related]
10. Implementation and application of anemia clinical practice guidelines.
Winn RJ; Muller RJ; Cella D
J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-33-9. PubMed ID: 23573552
[No Abstract] [Full Text] [Related]
11. Editorial: Update guidelines dermatologic oncology.
Nast A; Grabbe S
J Dtsch Dermatol Ges; 2013 Jun; 11 Suppl 3():1. PubMed ID: 23734886
[No Abstract] [Full Text] [Related]
12. Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.
Spaëth D
Expert Rev Anticancer Ther; 2008 Jun; 8(6):875-85. PubMed ID: 18533797
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances on the use of erythropoietin in oncology].
Spaëth D
Bull Cancer; 2006 May; 93(5):489-93. PubMed ID: 16777627
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin in cancer-related anemia.
Fenner MH; Ganser A
Curr Opin Oncol; 2008 Nov; 20(6):685-9. PubMed ID: 18841051
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of darbepoetin alfa in the management of patients with cancer.
Gordon MS
J Support Oncol; 2004; 2(2 Suppl 2):2-3. PubMed ID: 16108417
[No Abstract] [Full Text] [Related]
16. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
Nowrousian MR; Dunst J; Vaupel P
Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
[TBL] [Abstract][Full Text] [Related]
17. [Anemia and lung cancer].
Bréchot JM; Morère JF
Rev Pneumol Clin; 2008 Apr; 64(2):81-4. PubMed ID: 18589288
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietic agents in chemotherapy-induced anemia: a review of recent therapeutic progress, issues, and concerns.
Boccia RV
Curr Hematol Rep; 2004 Nov; 3(6):397-405. PubMed ID: 15496272
[TBL] [Abstract][Full Text] [Related]
19. [Anemia induced by solid tumor chemotherapy].
Stasi R; Abriani L; Beccaglia P; Terzoli E; Amadori S
Recenti Prog Med; 2002 Nov; 93(11):585-601. PubMed ID: 12489477
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced anemia.
Miller CB
Contrib Nephrol; 1991; 88():248-51; discussion 252-3. PubMed ID: 2040186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
